Angiodynamics (ANGO) Liabilities and Shareholders Equity (2009 - 2026)
Angiodynamics (ANGO) recorded Liabilities and Shareholders Equity of $241.93 million in fiscal Q1 2027 (quarter ended Aug 31, 2026), down 8.9% from $265.64 million a year earlier and down 9.4% from the prior quarter.
Angiodynamics (ANGO) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
At the end of FY2026 (ended May 31, 2026), Angiodynamics reported Liabilities and Shareholders Equity of $267.16 million, down 4.6% from FY2025.
- Annual Liabilities and Shareholders Equity has declined for seven straight fiscal years, with a five-year compound annual growth rate of -13.8% (FY2021 to FY2026).
- Across earlier fiscal years, Liabilities and Shareholders Equity came in at $280.14 million in FY2025 (-11.8%), $317.67 million in FY2024 (-40.4%), $532.64 million in FY2023 (-3.6%) and $552.75 million in FY2022 (-1.5%).
- The fiscal Q1 2027 figure is the lowest quarterly Liabilities and Shareholders Equity in data going back to fiscal Q4 2011.
- On a year-over-year basis, Liabilities and Shareholders Equity has declined for 15 consecutive quarters, with an average decline of 13.1% over the last eight quarters.
- Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 0.7% in fiscal Q2 2023, against a decline of 41.6% in fiscal Q2 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $267.16 million (Q4 2026), $260.68 million (Q3 2026) and $269.68 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 114.23 Bn |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 108.25 Bn |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 93.28 Bn |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 19.35 Bn |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 93.31 Bn |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | 47.25 Bn |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 45.46 Bn |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 14.14 Bn |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 40.18 Bn |
| 10 | Angiodynamics | 20.48 Mn | -146.80 Mn | 48.04 Mn | 241.93 Mn |
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 241.93 Mn |
| May 31, 2026 | 267.16 Mn |
| Feb 28, 2026 | 260.68 Mn |
| Nov 30, 2025 | 269.68 Mn |
| Aug 31, 2025 | 265.64 Mn |
| May 31, 2025 | 280.14 Mn |
| Feb 28, 2025 | 285.42 Mn |
| Nov 30, 2024 | 291.60 Mn |
| Aug 31, 2024 | 293.63 Mn |
| May 31, 2024 | 317.67 Mn |
| Feb 29, 2024 | 324.84 Mn |
| Nov 30, 2023 | 499.62 Mn |
| Aug 31, 2023 | 493.95 Mn |
| May 31, 2023 | 532.64 Mn |
| Feb 28, 2023 | 542.85 Mn |
| Nov 30, 2022 | 558.21 Mn |
| Aug 31, 2022 | 557.70 Mn |
| May 31, 2022 | 552.75 Mn |
| Feb 28, 2022 | 543.18 Mn |
| Nov 30, 2021 | 554.10 Mn |
Angiodynamics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ANGO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "ANGO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ANGO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();